Trafalgar International (GCAN) EBT Margin (2017 - 2021)
Trafalgar International (GCAN) posted EBT Margin of 308.5% for Q2 2021, down 113.44% on a QoQ basis from 2294.67% in Q2 2020, and down 260317.0% year-over-year from N/an in Q2 2020.
Analysis
Trafalgar International (GCAN) EBT Margin (2017 - 2021) Analysis & Trends
Trafalgar International has reported EBT Margin for 5 years, with the latest figure at 308.5% in Q2 2021.
- On a quarterly basis, EBT Margin fell 260317.0% year-over-year to 308.5% in Q2 2021; TTM through Dec 2021 was 4768.22%, a 295798.0% decrease from a year earlier, with the FY2021 full-year figure at 4768.22%, down 278843.0% from the prior year.
- EBT Margin was 308.5% for Q2 2021 at Trafalgar International, down from 2294.67% in the prior quarter.
- The five-year high for EBT Margin was 2294.67% in Q2 2020, with the low at 45065.75% in Q2 2017.
- Average EBT Margin over 5 years is 12544.97%, with a median of 2567.04% recorded in 2021.
- The sharpest annual moves came in 2018 and 2021: EBT Margin soared 4516509 bps in 2018, then slumped 260317 bps in 2021.
- Over 5 years, EBT Margin stood at 28305.15% in 2017, then soared by 100 bps to 99.34% in 2018, then slumped by 24619 bps to 24356.38% in 2019, then surged by 109 bps to 2294.67% in 2020, then plunged by 113 bps to 308.5% in 2021.
- The last three EBT Margin figures came in at 308.5% (Q2 2021), 2294.67% (Q2 2020), and 24356.38% (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 29.63% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -4.34% |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 12.17% |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 44.89% |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 47.58% |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -308.50% |
| Jun 30, 2020 | 2,294.67% |
| Dec 31, 2019 | -24,356.38% |
| Sep 30, 2019 | -4,825.57% |
| Jun 30, 2018 | 99.34% |
| Mar 31, 2018 | 107.62% |
| Sep 30, 2017 | -28,305.15% |
| Jun 30, 2017 | -45,065.75% |